뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg;   - film coated tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg   excipient: hypromellose lactose monohydrate   macrogol 4000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

alpha pharmaceuticals limited - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg;   - tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

viatris limited - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg;   - tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg   excipient: croscarmellose sodium magnesium stearate maize starch mannitol - indicated for the treatment of breast cancer

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg - tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide magnesium stearate microcrystalline cellulose povidone sodium starch glycolate

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tamoxifen citrate, quantity: 30.34 mg (equivalent: tamoxifen, qty 20 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; brilliant scarlet 4r; povidone - treatment of breast cancer tamoxifen lupin is indicated for the treatment of breast cancer.,primary reduction of breast cancer risk tamoxifen lupin is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg - tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose potato starch povidone sodium starch glycolate

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

astrazeneca limited - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg;   - tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg   excipient: croscarmellose sodium gelatin hypromellose lactose monohydrate macrogol 300 magnesium stearate maize starch titanium dioxide

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg;   - tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone purified talc

미국 - 영어 - NLM (National Library of Medicine)

proficient rx lp - tamoxifen citrate (unii: 7frv7310n6) (tamoxifen - unii:094zi81y45) - tamoxifen 20 mg - tamoxifen citrate tablets, usp are effective in the treatment of metastatic breast cancer in women and men. in premenopausal women with metastatic breast cancer, tamoxifen is an alternative to oophorectomy or ovarian irradiation. available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from tamoxifen therapy. tamoxifen citrate tablets, usp are indicated for the treatment of node-positive breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. in some tamoxifen adjuvant studies, most of the benefit to date has been in the subgroup with four or more positive axillary nodes. tamoxifen citrate tablets, usp are indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. the estrogen and progesterone receptor values may help to predict whether adjuvant tamoxifen therapy is likely to b

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tamoxifen citrate, quantity: 30.4 mg (equivalent: tamoxifen, qty 20 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; titanium dioxide; microcrystalline cellulose; povidone; hypromellose; macrogol 4000; magnesium stearate; sodium starch glycollate - treatment of breast cancer. ? tamoxifen sandoz is indicated for the treatment of breast cancer.,primary reduction of breast cancer risk ? tamoxifen sandoz is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).